Kynurenic acid/Quinolinic acid ratio

Basic information

Metabolite name	Kynurenic acid/Quinolinic acid ratio
	N/A
	N/A
	N/A
Synonyms	Kynurenic acid/Quinolinic acid
No. of studies	15

Relationship between Kynurenic acid/Quinolinic acid ratio and depression (count: 15)

Study	Study Type	Comparison groups	Tissue	Organism	Up/Down regulated
Study M1029	Type1	Crohn’s disease model group vs. control group	Hippocampus	Sprague-Dawley rat	Down
Study M1029	Type2	Crohn’s disease model + moxibustion + 1-methyltryptophan group vs. Crohn’s disease model group	Hippocampus	Sprague-Dawley rat	Up
Study M1029	Type2	Crohn’s disease model + moxibustion group vs. Crohn’s disease model group	Hippocampus	Sprague-Dawley rat	Up
Study M1035	Type2	mood disorder group, after tryptophan-rich diet vs. baseline	Urine	Human	Up
Study M139	Type1	dMDD group vs. control group	Serum	Human	Down
Study M143	Type1	depressed group vs. control group	Serum	Human	Down
Study M149	Type1	MDD group vs. control group	Serum	Human	Down
Study M189	Type1	depressed group vs. control group	Serum	Human	Down
Study M470	Type1	MDD group vs. control group	Plasma	Human	Down
Study M518	Type1	depression group vs. control group	Plasma	Human	Down
Study M542	Type1	CUMS group vs. control group	Urine	Sprague-Dawley rat	Down
Study M542	Type1	CUMS group vs. control group	Plasma	Sprague-Dawley rat	Down
Study M724	Type1	MDD group vs. control group	Serum	Human	Down
Study M865	Type1	HIV with depression group vs. HIV without depression group	Plasma	Human	Up
Study M876	Type1	MDD group vs. control group	Plasma	Human	Down
Study M879	Type1	unipolar depression group vs. control group	Plasma	Human	Down
Study M897	Type2	behavioral activation therapy, post-therapy vs. pre-therapy	Serum	Human	Up
Study M976	Type1	small intestinal bacterial overgrowth group vs. control group	Urine	Human	Down
Study M976	Type2	small intestinal bacterial overgrowth group, after rifaximin treatment vs. baseline	Urine	Human	Up